110 related articles for article (PubMed ID: 2930575)
21. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class.
Owellen RJ; Hartke CA; Dickerson RM; Hains FO
Cancer Res; 1976 Apr; 36(4):1499-502. PubMed ID: 1260766
[TBL] [Abstract][Full Text] [Related]
22. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
Ngan VK; Bellman K; Panda D; Hill BT; Jordan MA; Wilson L
Cancer Res; 2000 Sep; 60(18):5045-51. PubMed ID: 11016627
[TBL] [Abstract][Full Text] [Related]
23. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
Makarov AA; Tsvetkov PO; Villard C; Esquieu D; Pourroy B; Fahy J; Braguer D; Peyrot V; Lafitte D
Biochemistry; 2007 Dec; 46(51):14899-906. PubMed ID: 18052208
[TBL] [Abstract][Full Text] [Related]
24. Taxol binds to polymerized tubulin in vitro.
Parness J; Horwitz SB
J Cell Biol; 1981 Nov; 91(2 Pt 1):479-87. PubMed ID: 6118377
[TBL] [Abstract][Full Text] [Related]
25. Rhazinilam mimics the cellular effects of taxol by different mechanisms of action.
David B; Sévenet T; Morgat M; Guénard G; Moisand A; Tollon Y; Thoison O; Wright M
Cell Motil Cytoskeleton; 1994; 28(4):317-26. PubMed ID: 7954858
[TBL] [Abstract][Full Text] [Related]
26. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
Jordan MA; Horwitz SB; Lobert S; Correia JJ
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
[TBL] [Abstract][Full Text] [Related]
27. In situ response to vinka alkaloids by microtubules in cultured post-implanted mouse embryos.
Meininger V; Binet S; Chaineau E; Fellous A
Biol Cell; 1990; 68(1):21-9. PubMed ID: 2180513
[TBL] [Abstract][Full Text] [Related]
28. Ultra-potent vinblastine analogues improve on-target activity of the parent microtubulin-targeting compound.
Radakovic A; Boger DL
Bioorg Med Chem Lett; 2019 Jun; 29(11):1370-1374. PubMed ID: 30952593
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of interaction of vinca alkaloids with tubulin: catharanthine and vindoline.
Prakash V; Timasheff SN
Biochemistry; 1991 Jan; 30(3):873-80. PubMed ID: 1988072
[TBL] [Abstract][Full Text] [Related]
30. Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization.
Dumontet C; Jaffrezou JP; Tsuchiya E; Duran GE; Chen KG; Derry WB; Wilson L; Jordan MA; Sikic BI
Bull Cancer; 2004 May; 91(5):E81-112. PubMed ID: 15568225
[TBL] [Abstract][Full Text] [Related]
31. Differential in vitro action of S-12363, a new vinblastine derivative, and of its epimer on microtubule proteins.
Wright M; Garès M; Verdier-Pinard P; Moisand A; Berlion M; Legrand JJ; Bizzari JP
Cancer Chemother Pharmacol; 1991; 28(6):434-40. PubMed ID: 1934248
[TBL] [Abstract][Full Text] [Related]
32. BM6, a new semi-synthetic vinca alkaloid, exhibits its potent in vivo anti-tumor activities via its high binding affinity for tubulin and improved pharmacokinetic profiles.
Li W; Shao Y; Hu L; Zhang X; Chen Y; Tong L; Li C; Shen X; Ding J
Cancer Biol Ther; 2007 May; 6(5):787-94. PubMed ID: 17387272
[TBL] [Abstract][Full Text] [Related]
33. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
[TBL] [Abstract][Full Text] [Related]
34. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain.
Bai R; Pettit GR; Hamel E
Biochem Pharmacol; 1990 Jun; 39(12):1941-9. PubMed ID: 2353935
[TBL] [Abstract][Full Text] [Related]
35. Binding of vinblastine to stabilized microtubules.
Singer WD; Jordan MA; Wilson L; Himes RH
Mol Pharmacol; 1989 Sep; 36(3):366-70. PubMed ID: 2571072
[TBL] [Abstract][Full Text] [Related]
36. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
37. Effects of microtubule inhibitors on etoposide accumulation and DNA damage in human K562 cells in vitro.
Yalowich JC
Cancer Res; 1987 Feb; 47(4):1010-5. PubMed ID: 2879622
[TBL] [Abstract][Full Text] [Related]
38. Syntheses and biological evaluation of vinblastine congeners.
Kuehne ME; Bornmann WG; Markó I; Qin Y; LeBoulluec KL; Frasier DA; Xu F; Mulamba T; Ensinger CL; Borman LS; Huot AE; Exon C; Bizzarro FT; Cheung JB; Bane SL
Org Biomol Chem; 2003 Jun; 1(12):2120-36. PubMed ID: 12945903
[TBL] [Abstract][Full Text] [Related]
39. Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules.
Bai R; Friedman SJ; Pettit GR; Hamel E
Biochem Pharmacol; 1992 Jun; 43(12):2637-45. PubMed ID: 1632820
[TBL] [Abstract][Full Text] [Related]
40. Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells.
Kawamura KI; Grabowski D; Weizer K; Bukowski R; Ganapathi R
Br J Cancer; 1996 Jan; 73(2):183-8. PubMed ID: 8546904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
